Skip to content
NNN191919

Drawing based on the label description. No photo yet.

“500 mg, light pink to pink, biconvex, capsule-shaped, film-coated tablets, debossed with "N" on one side and "19" on the other side”

N 19 pill

Pill with imprint N 19 is pink, capsule, 20 mm and has been identified as Dapagliflozin and Metformin Hydrochloride 10 mg / 500 mg. It is used for type 2 diabetes and heart failure. It is supplied by Aurobindo Pharma Limited.

Dapagliflozin and Metformin Hydrochloride 10 mg / 500 mg

Imprint
N 19
Strength
Dapagliflozin 10 mg / Metformin Hydrochloride 500 mg
Used for
Type 2 diabetes and heart failure
Color
Pink
Shape
Capsule / oblong
Size
20 mm
Score
No score line
Form
Tablet, film coated, extended release
Manufacturer
Aurobindo Pharma Limited
Drug class
Diabetes medicine (SGLT2 inhibitor)
NDC
59651-156, 59651-156-30, 59651-156-05

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Dapagliflozin and Metformin pills and guides

What is Dapagliflozin and Metformin used for?

Dapagliflozin and Metformin is used for type 2 diabetes and heart failure.

Medicine type
Diabetes medicine (SGLT2 inhibitor); diabetes medicine (biguanide)
Official uses from the US prescribing label

Dapagliflozin and metformin hydrochloride extended-release tablets are a combination of dapagliflozin and metformin hydrochloride (HCl) extended-release, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Dapagliflozin, when used as a component of dapagliflozin and metformin hydrochloride extended-release tablets, is indicated in adults with type 2 diabetes mellitus to reduce the risk of:

  • Sustained eGFR decline, end-stage kidney disease, cardiovascular (CV) death, and hospitalization for heart failure in patients with chronic kidney disease at risk of progression.
  • CV death, hospitalization for heart failure, and urgent heart failure visit in patients with heart failure.
  • Hospitalization for heart failure in patients with type 2 diabetes mellitus and either established CV disease or multiple CV risk factors.

Limitations of Use

  • Dapagliflozin and metformin hydrochloride extended-release tablets are not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus.
  • Because of the metformin hydrochloride component, the use of dapagliflozin and metformin hydrochloride extended-release tablets is limited to patients with type 2 diabetes mellitus for all indications.
  • Dapagliflozin and metformin hydrochloride extended-release tablets are not recommended for the treatment of chronic kidney disease in patients with polycystic kidney disease or patients requiring or with a recent history of immunosuppressive therapy for kidney disease. Dapagliflozin and metformin hydrochloride extended-release tablets are not expected to be effective in these populations.

Pediatric use information is approved for AstraZeneca AB’s Xigduo ® XR (dapagliflozin and metformin hydrochloride) Extended-Release Tablets. However, due to AstraZeneca AB’s marketing exclusivity rights, this drug product is not labeled with that information.

From the FDA-approved label on DailyMed (published Sep 24, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows N and the other side shows 19.
  • It is pink, capsule, 20 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Dapagliflozin, Metformin Hydrochloride

Inactive: Carboxymethylcellulose Sodium, Unspecified, Silicon Dioxide, Crospovidone (120 .mu.m), Glyceryl Mono- and Dicaprylocaprate, Hypromellose 2208 (100000 Mpa.s), Hypromellose 2910 (5 Mpa.s), Mannitol, Microcrystalline Cellulose, Polyvinyl Alcohol, Unspecified, Sodium Lauryl Sulfate, Sodium Stearyl Fumarate, Talc, Titanium Dioxide, Ferric Oxide Yellow, Ferric Oxide Red

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Dapagliflozin and Metformin pills